Always cite the published version, so the author(s) will receive recognition through services that track citation counts, e.g. Scopus. If you need to cite the page number of the TSpace version (original manuscript or accepted manuscript) because you cannot access the published version, then cite the TSpace version in addition to the published version using the permanent URI (handle) found on the record page. Purpose: Multimodal micro-imaging in preclinical models is used to examine the effect of spinal 21 metastases on bony structure, however the evaluation of tumour burden and its effect on 22 microstructure has thus far been mainly qualitative or semi-quantitative. Quantitative analysis of 23 multi-modality imaging is a time consuming task, motivating automated methods. As such, this 24 study aimed to develop a low complexity semi-automated multimodal µCT/µMR based approach 25 to segment rat vertebral structure affected by mixed osteolytic/osteoblastic destruction. 26
visualization), T1-weighted µMR imaging (for bone registration) and T2-weighted µMR 29 imaging (for osteolytic tumour visualization) were conducted on one L1, three L2, and one L3 30 vertebrae (excised). One sample (L1-L3) was processed for undecalcified histology and 31 stained with Goldner's trichome. The µCT and µMR images were registered using a 3D rigid 32 registration algorithm with a mutual information metric. The vertebral micro-architecture was 33 segmented from the µCT images using atlas-based demons deformable registration, levelset 34 curvature evolution, and intensity based thresholding techniques. The µCT based segmentation 35 contours of the whole vertebrae were used to mask the T2-weighted µMR images, from which 36 the osteolytic tumour tissue was segmented (intensity based thresholding). 37
Results: Accurate registration of µCT and µMRI modalities yielded accurate and precise 38 segmentation of whole vertebrae, trabecular centrums, individual trabeculae, and osteolytic 39 tumour tissue. While the algorithm identified the osteoblastic tumour attached to the vertebral 40
Introduction 48
The skeleton is one of the most common sites of metastatic disease; bone metastasis accounts for 49 skeletal lesions in 40 times as many patients as those affected by all other forms of bone cancer 50 combined 1 . Skeletal lesions most commonly appear in the spine 2 and can present as osteolytic 51 (bone destroying), osteoblastic (excess bone deposition), or mixed osteolytic/ osteoblastic. 52
Modern cancer therapies have resulted in a significant increase in the occurrence of mixed 53 vertebral lesions with more diffuse patterns of involvement 3, 4 . Understanding the structural 54 implications of complex patterns of metastatic involvement in the spine is an important step 55 towards the development and appropriate use of interventions to prevent fracture and associated 56 neurologic complications 5, 6 . 57
Preclinical models are commonly used to represent metastatic disease in the skeleton 7, 8, 9, 10, 11, 58 12 . Widespread access to high resolution imaging modalities has made it possible to visualize the 59 pattern of metastatic disease within the skeleton in preclinical models on a micro-scale. Such 60 image data can be used towards building accurate mathematical models to quantify the impact of 61 bone quality (including architecture and material properties), and tumour burden on bone 62 stability and to predict the risk and location of fracture. Development of such models requires 63 accurate segmentation of the vertebral structure including bone, marrow and both osteolytic and 64 osteoblastic tumour tissue. However, the amount of data contained in these high resolution scans 65 motivates the development of automated segmentation methods. 66
In previous works 13, 14 , semi-automated CT-based methods have been developed for 67 quantification of metastatic disease in human vertebral bodies. In this work, the quantification 68 scheme was based on conventional CT in which osteolytic destruction and osteoblastic 69 deposition appear as low and high intensity voxels respectively. Conventional CT is however not 70 suitable for the examination of micro-structural effects. We further extended this work and 71 developed a µCT based automated method to segment the full healthy vertebrae (including the 72 posterior elements) and vertebrae with osteolytic metastatic involvement in a rat model 15 . This 73 approach was able to accurately segment whole vertebrae, the trabecular centrum, and the 74 individual trabecular mesh. In this work tumour burden was evaluated as the volume of 75 osteolytic destruction; both tumour tissue and bone marrow appear as low intensity voxels in the 76 μCT images, however, and thus the true tumour burden was not quantified. 77
A solution to determine the true extent of tumour burden within bone is to employ multi-modal 78 imaging. MRI yields robust images of soft tissue structures and is able to differentiate tumour 79 burden (higher intensity) from bone marrow. However, registration of this data with the bone 80 information generated from the μCT image data is necessary to spatially resolve the relative 81 distributions of the soft and hard tissues. 82
Previous works have introduced different methods for multi-modal registration of medical 83 images 16 -19 . All of these works use a mutual information metric to perform the registration, 84 however the techniques used to assure accuracy in the registration differ. Chen The objective of this study was to develop a low complexity highly-automated multimodal 94 approach to segment the rat vertebral structure and quantify metastatic tumour burden within 95 bone using a combination of µCT and µMR modalities. We hypothesize that semi-automated 96 multi-modal analysis applied to 3D μCT and μMRI reconstructions will allow registration of 97 whole vertebrae affected by mixed osteolytic/osteoblastic metastases and yield accurate and 98 repeatable segmentation of both bone and soft tissue elements within the bone. 99
Materials and Methods 100
Animal Model: Osteolytic/osteoblastic spinal metastasis were developed using canine Ace-1 101 prostate cancer cells in three 3 week old rnu/rnu rats. Ace-1 cells were previously transfected 102 with the luciferase gene to enable bioluminescent image monitoring of tumour growth within the 103 rodent model. Cells were cultured for 7 days using a standard protocol (DMEM/F12 media with 104
10% FBS and 1% antibiotics). One and a half million cells in 200µl of media were injected into 105
the left ventricle of anaesthetized rats (2% isofluorane/oxygen). The rats were weighed, marked 106 and monitored until fully awake. 107
Bioluminescence imaging (IVIS Imaging System, Caliper Life Science, Hopkinton, MA) was 108 performed on day 14 following intracardiac cancer cell injection to confirm the establishment of 109 metastases. Luciferin (Xenogen Corp., Alameda, CA) was dissolved in 0.9 % NaCl solution at a 110 concentration of 30mg/ml and 60 mg/kg injected intra-peritoneally to anaesthetized animals (2% 111 isofluorane/oxygen). After five minutes, the bioluminescent signal was acquired with a 1 minute 112 integration time. The signal was captured as the absolute total flux (# of photons emitted per 113 steradian cm 2 ) and analyzed using Living image software with the bioluminescence image 114 overlaid on a plain photograph. Following subsequent bioluminescent confirmation of vertebral 115 metastatic involvement at day 21, the rats were sacrificed and their L1-L3 vertebral levels were 116 excised. The L1-L3 motion segment of one rat was immediately fixed in 4% paraformaldehyde 117 8, 20 . 118
119
Image Acquisition: 120
µCT: First to third lumbar vertebrae were dissected and scanned at (14 μm) 3 isotropic resolution 121 using a μCT scanner using an x-ray source at 90 mA and 80 kV, with 907 views covering 360° 122 of rotation. The scan time was 2.5 hours. (GE Explore Locus, General Electric Company, 123
Fairfield, USA). The 3D volume (with intensities converted to Hounsfield units) was 124 reconstructed using the GE Explore Reconstruction Utility. The μCT was able to display cortical 125 and trabecular bone and well as osteoblastic tumour as high intensity voxels. Bone marrow and 126 osteolytic tumour appeared as low intensity values, which were not distinguishable from each 127 other ( Figure 1a ). 128 µMR: MRI used a 7 Tesla pre-clinical Biospec system (Bruker, Ettlingen, Germany) with a 129 quadrature birdcage coil tuned to the 1H frequency (~300.3 MHz), custom-built by Stark 130
Contrast MRI Research, Germany. This coil was specifically designed for good signal to noise 131 ratio in imaging ex vivo bone. The coil was fixed tuned to an average load as load change is not 132 essential for small sizes. The inner diameter of the coil was 17mm, to fit a 15 cc Falcon tube, and 133 the outer diameter was set to 60mm, to fit the B-GA6S gradient coil insert of the Bruker system. 134
For imaging with this coil, the spine was embedded in agarose gel within a 15 cc Falcon tube. 135
Imaging then proceeded using 30.8 mm field-of-view along the spine length, and 15.4 mm field-136 of-view in each transverse plane. Spine anatomy was then resolved to a (60 µm) 3 voxel size 137 using a 512x256x256 matrix with 13.5 hour acquisitions. 138
The first scan presented a T1-weighting to accentuate bone ultrastructure and ensure accurate 139 µCT and µMRI registration. Data acquisition parameters included an echo time (TE) of 7.6 ms,repetition time (TR) of 500 ms, RARE factor of 2, and 3 signal averages. Using these 141 parameters, the boundaries of the trabecular structure were clearly visible, though bone marrow 142 and osteolytic tumour could not be visualized distinctly (Fig. 1b) . 143
The second scan presented a T2-weighting to accentuate soft tissue contrast and clearly 144 differentiate lower intensity bone marrow from higher intensity tumour tissue (Fig. 1C) In histological analysis osteoblastic tumour can be qualitatively characterized as a disorganized 159 arrangement of osteoblastic cells, however, in µCT images the intensity of the voxels 160 corresponding to osteoblastic tumour is equivalent to that of non-pathologic newly formed bone. 161
Semi-Automated Multimodal Segmentation 162
Rigid Registration: All μMR and μCT images were resampled to (34.9 μm) 3 and manually 163 aligned to a global axis (AmiraDEV 4.1, Visage Imaging, USA). The aligned μCT scan was 164 further registered to the bone μMRI data using a 3D rigid registration algorithm (AmiraDEV 165 4.1). In this registration, the μCT was chosen as the moving image and the μMRI was chosen as 166 the fixed image. A quasi Newton optimizer 21 . was used with an initial optimizer step of (10 -3 × 167 bounding box) and final optimizer step of (10 As validated by histology the osteoblastic tumour was predominantly attached to the periosteal 200 surface of the cortical shell (Figures 1 and 3b) . To segment the osteoblastic deposition, the 201 trabecular centrum was removed from the whole vertebral segmentation, leaving the outside 202 band of the vertebra including the cortical shell and osteoblastic tumour. Intensity-based 203 histogram analysis was performed on this region. Based on concurrency with manual 204 segmentation, a threshold was chosen as a function of the mean (µ) and the standard deviation 205 (σ) to segment the osteoblastic tissue, with an upper bound of (µ + σ) and a lower bound of (µ -206 σ/4) for L1, (µ -σ/2) for L2 and L3. (Figure 3c) . 207
208
The images were then edge enhanced and resampled from (14μm) 3 to (8.725μm) 3 prior to the 209 next step of the segmentation. In contrast to earlier work done on rat vertebrae affected by 210 
Results

238
The automated segmentation of the whole vertebrae yielded 91% concurrency in L1, 91.9% ± 239 2.8% concurrency in L2 and 92% concurrency in L3 when compared to manually refined 240 segmentations. The segmentation of the trabecular centrum yielded 93%, 93.8% ± 1.2%, and 241 92% concurrency in L1, L2 and L3 respectively when compared to the manually refined 242 a) b) c) (1) segmentations. The output of the segmentation of the individual trabecular network did not 243
require any manual refinement. The osteoblastic tissue segmentation on the outside of the 244 cortical shell yielded 80% to 87% concurrency when compared to manually refined 245 segmentations. Although based on histological analysis osteoblastic tumour was primarily 246 concentrated on the outside of the trabecular centrum, in a few slices they were also detected 247 inside the trabecular centrum. Despite several attempts, including histogram based approaches 248 applied inside the trabecular centrum (with and without the growth plate), we were not able to 249 distinguish newly formed healthy bone from osteoblastic tumour tissue in these vertebrae using 250 the μCT or μMR image data, as they possess the same tomographical attitude. 251
The customized μMR coil enabled good quality image acquisition of the bony structure as well 252 as good quality images visualizing the non-bone soft tissue structures (bone marrow and 253 osteolytic tumour). Using the contrast μMRI, we were able to accurately segment the osteolytic 254 tumour with no need for further manual refinement. 255
Discussion 256
In this work we have presented a semi-automated multimodal approach to segment rat vertebrae 257 affected by mixed osteolytic / osteoblastic tumour. The whole bone vertebral segmentation 258 algorithm was able to segment metastatic vertebrae despite extensive osteolytic destruction and 259 osteoblastic deposition caused by the aggressive behavior of tumour cells, with very limited user 260 interaction (~1minute). The algorithm was even more robust in segmenting the trabecular 261 centrum, and individual trabecular network clearly accounting for the boundaries of the bone and 262 non bone structures (92-95% concurrencies with manually refined segmentations). 263
The algorithm was limited in segmenting the osteoblastic voxels (lower volumetric concurrency 264 ~80%) as they appeared as the same intensity as newly formed bone. Future work on older ratsmay provide a more sensible osteoblastic deposition pattern that would be more amenable tofinite element analysis (FEA and μFEA), lower resolutions have been shown to be sufficient to 288 yield accurate analysis of vertebral biomechanical behaviour under load 23, 24 . 289
The highly automated registration and segmentation algorithm presented in this study has 290 demonstrated its ability to quantify skeletal structure and metastatic involvement in the spine. 291
Such information could be used to develop mathematical models of vertebrae in order to analyze 292 strain patterns generated through finite element modeling or the comparison of loaded and 293 unloaded 3D images, to estimate ultimate failure loads and to predict fracture locations. 294
Moreover, it could readily be used to analyze micro-structural parameters of metastatic vertebra 295 in preclinical applications looking at quantitative evaluation of new and existing treatments 296 aimed at spinal lesions. 297
